XBIO

XENETIC BIOSCIENCES INC

XBIO·984015602·US·Common Stock·Healthcare - Biotechnology-13D/G

XBIO (XENETIC BIOSCIENCES INC) is held by 4 institutional investors as of Q2 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($341,750), GEODE CAPITAL MANAGEMENT, LLC ($50,723), VANGUARD CAPITAL MANAGEMENT LLC ($36,902). Net institutional sentiment: Mixed.

4
Holders
$429,812
Total Value
50% (4)
Consensus
2 buying - 2 selling
13F: Insider & Congress: Updated regularly
XBIO

Smart Money Verdict

View all
Loading verdict
Held by 4 funds

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists May 29, 2026 · Congress none

ActivistMLMichael Liu5.5%May 29, 2026
ActivistRenaissance Technologies LLCRenaissance Technologies LLC6.0%May 14, 2026

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
117,440(-14.6%)$341,7500.0%+63.91%
0
Decreased
17,423(-18.7%)$50,7230.0%+9.43%
0
Increased
12,681(+88.4%)$36,9020.0%+48.34%
21
New
150$4370.0%+32.65%
17
XBIOXBIOXENETIC BIOSCIENCES INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used